Prediction of Urinary Symptoms After 125Iodine Prostate Brachytherapy

Clinical Oncology

Volumn 18, Issue 4, 2006, Pages 326-332

  Kelly, K ^a   Swindell, R ^b   Routledge, J ^a   Burns, M ^a   Logue, J P ^a   Wylie, J P ^a  

^a Department of Clinical Oncology ^*

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Brachytherapy; International Prostate Symptom Scores (IPSS); iodine 125; prostate cancer; urinary symptoms

Indexed keywords

GONADORELIN DERIVATIVE; IODINE 125; TAMSULOSIN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CATHETERIZATION; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; DOSIMETRY; ECHOGRAPHY; EXPERIENCE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORBIDITY; ORGAN SIZE; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE SURGERY; QUESTIONNAIRE; SCORING SYSTEM; SYMPTOM; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINARY TRACT DISEASE; URINE RETENTION;

AGED; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; URINARY CATHETERIZATION; URINATION DISORDERS;

EID: 33645886947     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2006.02.007     Document Type: Article

References (23)

1. Cancer Research UK. Prostate CancerStats (2002), Cancer Research UK, London
2. Henderson A., Cahill D., Laing R.W., and Langley S.E. 125 Iodine prostate brachytherapy: outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics. BJU Int 90 (2002) 567-572
3. 125iodine prostate brachytherapy in the UK. A prospective study. Clin Oncol 16 (2004) 95-104
4. Al-Booz, Ash D., Bottomley D.M., et al. Short-term morbidity and acceptability of 125iodine implantation for localized carcinoma of the prostate. BJU Int 83 (1999) 53-56
5. Crook J., McLean M., Catton C., et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys 52 (2002) 453-460
6. Bucci J., Morris W.J., Keyes M., Spadinger I., Sidhu S., and Moravan V. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 53 (2002) 91-98
7. Zelefsky M.J., Hollister T., Raben A., et al. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localised prostate cancer. Int J Radiat Oncol Biol Phys 47 (2000) 1261-1266
8. Stock N.N., and Stone G. Complications following permanent prostate brachytherapy. Eur Urol 41 (2002) 427-433
9. Gelblum D.Y., Potters L., Ashley R., Waldbaum R., Wang X., and Leibel S. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45 (1999) 59-67
10. Salem N., Simonian-Sauve M., Rosello R., et al. Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer. Radiother Oncol 66 (2003) 159-165
11. Lee W.R., McQuellon R.P., Case L.D., DeGuzman A.F., and McCullough D.L. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer. J Urol 162 (1999) 403-406
12. Locke J., Ellis W., Wallner K., Cavanagh W., and Blasko J. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study. Int J Radiat Oncol Biol Phys 52 (2002) 712-719
13. Talcott J.A., Clark J.A., Stark P.C., et al. Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol 166 (2001) 494-499
14. 125I brachytherapy of the prostate. BJU Int 92 (2003) 555-558
15. Kleinberg L., Wallner K., Roy J., et al. Treatment-related symptoms during the first year following transperineal I-125 prostate implantation. Int J Radiat Oncol Biol 28 (1994) 985-990
16. Desai J., Stock R.G., Stone N.N., et al. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat Oncol Invest 6 (1998) 135-141
17. Merrick G.S., Butler W.M., Lief J.H., et al. Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Biol 47 (2000) 121-128
18. Lee W.R. The role of androgen deprivation therapy combined with prostate brachytherapy. Urology 60 (2002) 39-44
19. Barry M.J., Fowler F.J.J., O'Leary M.P., et al. The American Urological Association symptom index for benign prostatic hyperplasia. The measurement committee of the American Urological Association. J Urol 148 (1992) 1549-1557
20. Zigmond A.S., and Snaith R.P. Hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983) 361-370
21. Cesaretti J.A., Stone N.N., and Stock R.G. Urinary symptom flare following I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 56 (2003) 1085-1092
22. Litwin M.S. Health related quality of life in older men without prostate cancer. J Urol 161 (1999) 1180-1184
23. Wallner K. Improved outcomes with radiation for prostate cancer. Hematol Oncol Clin North Am 15 (2001) 359-375